CRYO CELL INTERNATIONAL INC

Cryopreserves newborn cord blood and tissue stem cells for expectant families.

CCEL | NYSE

Overview

Corporate Details

ISIN(s):: US2288951088
LEI:
Country:: United States of America
Address:: 700 BROOKER CREEK BLVD, 34677 OLDSMAR
Website:: https://www.cryo-cell.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Cryo-Cell International, Inc., established in 1989, is the world's first private cord blood bank. The company provides premier cryopreservation services for umbilical cord blood and cord tissue stem cells. Its core business involves the collection, processing, and long-term cryogenic storage of these cells for exclusive family use. These stem cells can be used to treat numerous diseases and conditions, with ongoing research expanding their potential applications in regenerative medicine. Trusted by over 500,000 parents globally, Cryo-Cell utilizes advanced processing technologies and a proprietary five-chamber storage bag to ensure the long-term viability and multiple treatment opportunities from a single collection. The company's target market consists of expectant families seeking to preserve their newborn's stem cells for future health needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all CRYO CELL INTERNATIONAL INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CRYO CELL INTERNATIONAL INC

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for CRYO CELL INTERNATIONAL INC via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Model Solution Co., Ltd. One-stop prototyping & low-volume production for IT, electronics, and medical hardware.	South Korea	417970
Modus Therapeutics Holding AB Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.	Sweden	MODTX
Moleculin Biotech, Inc. Developing therapies for hard-to-treat tumors (like AML) and viruses.	United States of America	MBRX
Molecure S.A. Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.	Poland	MOC
Moolec Science SA Uses Molecular Farming to grow animal proteins in plants for food, feed, and supplement industries.	United States of America	MLEC
MoonLake Immunotherapeutics Developing Nanobody therapies for inflammatory and immunologic diseases like psoriatic arthritis.	United States of America	MLTX
Mural Oncology plc Developing cytokine-based immunotherapies for difficult-to-treat cancers and solid tumors.	United States of America	MURA
Mural Oncology PLC Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.	Ireland	MURA
N2OFF, Inc. Sustainable agri-tech for food preservation, emissions reduction, and renewable energy.	United States of America	NITO
NANO MRNA Co.,Ltd. Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.	Japan	4571